HealthLeaders Media June 23, 2021
Jack O'Brien

PwC attributed the increase in deal activity to several factors, including “capital availability, regulatory shifts, evolving competitive dynamics, promising technologies and commitments to patient-centricity.”

Deal volumes in the health services sector this year are “unprecedented,” according to a PricewaterhouseCoopers (PwC) report released Tuesday afternoon.

Following a slump in early 2020, coinciding with the start of the domestic spread of COVID-19, health services deals rebounded with 352 transactions in Q4 2020, a record for one quarter, only to be topped by 426 deals in Q1 2021. Additionally, the sector has seen six ‘megadeals’ valued at more than $5 billion.

PwC attributed the increase in deal activity to several factors, including “capital availability, regulatory shifts, evolving competitive dynamics, promising technologies and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma / Biotech, Provider, Survey / Study, Trends
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Novant Health and CHS counter FTC bid to block hospital deal
Informatica says it's not for sale, following Salesforce's reported interest in $10 billion deal
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
CHS to sell Tennessee hospital for $160M

Share This Article